Agustin, Rosalinda L.

HRN: 20-95-01  Sex: Female

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
01/24/2023
CEFTRIAXONE 1G (VIAL)
01/24/2023
01/30/2023
IVT
2g
OD
UTI
Waiting Final Action 
01/25/2023
METRONIDAZOLE 5MG/ML, 100ML (VIAL)
01/25/2023
02/01/2023
IV
500mg
Q8H
Cholecystitis
Waiting Final Action 
01/29/2023
PIPERACILLIN + TAZOBACTAM 4.5G (VLS)
01/29/2023
02/04/2023
IV
4 5gram
Q8hrs
Cholecystolithiasis With Cholecystitis
Waiting Final Action 

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: